| Literature DB >> 29926160 |
Labrinus van Manen1, Jouke Dijkstra2, Claude Boccara3,4, Emilie Benoit4, Alexander L Vahrmeijer1, Michalina J Gora5, J Sven D Mieog6.
Abstract
INTRODUCTION: Tumor detection and visualization plays a key role in the clinical workflow of a patient with suspected cancer, both in the diagnosis and treatment. Several optical imaging techniques have been evaluated for guidance during oncological interventions. Optical coherence tomography (OCT) is a technique which has been widely evaluated during the past decades. This review aims to determine the clinical usefulness of OCT during cancer interventions focussing on qualitative features, quantitative features and the diagnostic value of OCT.Entities:
Keywords: Cancer; Image-guided surgery; Optical coherence tomography; Optical imaging.; Tumor
Mesh:
Year: 2018 PMID: 29926160 PMCID: PMC6153603 DOI: 10.1007/s00432-018-2690-9
Source DB: PubMed Journal: J Cancer Res Clin Oncol ISSN: 0171-5216 Impact factor: 4.553
Fig. 1Flow diagram of study inclusion
Overview of clinical studies evaluating the diagnostic value of optical coherence tomography for tumor detection
| Tumor type | References | Technical specifications | Study design | Analysis | Diagnostic value | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Technique, | Resolution: axial × lateral (µm) | Penetration depth (mm) | Acquisition time/image (s) | Implementation | Samples | Sensitivity (%) | Specificity (%) | Detection rate (%) | ||||
| Basal cell carcinoma | Mogensen et al. ( | (Polarization-sensitive) OCT, | 8 × 24 | NS | 3 | 220 | Ex vivo | Suspected lesions | 6 reviewers of which 2 reviewed all images | 79, 94 | 85, 96 | – |
| Jorgensen et al. ( | OCT, | 10 × 20 | 1.3 | 4 | 78 | Ex vivo | Suspected lesions | Machine based learning | – | – | 81 | |
| Ulrich et al. ( | OCT, | 5 × 7.5 | 1.2-2 | NS | 235 | In vivo | Suspected lesions | Clinicians of participating centres | 96 | 75 | – | |
| Cunha et al. ( | OCT, | 10 × 7.5 | 1.5 | NS | 75 | Ex vivo | Resection margin | 2 Mohs surgeons | 19 | 56 | – | |
| Maier et al. ( | HD-OCT, | 3 × 3 | 0.45–0.75 | 120 | 80 | Ex vivo | Resection margin | 1 Experienced investigator | 74 | 64 | – | |
| Oral cancer | Wilder-Smith et al. ( | OCT, | 5–10 (not exactly specified) | 1–2 | 1.5 | 50 | Ex vivo | Biopsies | 2 Reviewers | 93 | 93 | – |
| Hamdoon et al. ( | OCT, | < 10 × < 10 | 1.5 | < 0.1 | 112 | Ex vivo | Resected SCC specimens | 2 Reviewers | 82 | 87 | – | |
| De Leeuw et al. ( | FF-OCT, | 1.5 × 1.0 | NS | NS | 57 | Ex vivo | Resected head and neck specimens | 2 Pathologists | 88, 90 | 81, 87 | – | |
| Lung cancer | Hariri et al. ( | OCT, | 6 × 30 | 2–3 | NS | 82 | Ex vivo | Resection specimens | 1 Pathologist | 80 (AC) | 89 (AC) | – |
| Breast cancer | Nguyen et al. ( | OCT, | 6 × 35 | 1–2 | 5 | 210 | Ex vivo | Resection margin | 1 Trained researcher | 100 | 82 | – |
| Zysk et al. ( | Handheld OCT, | < 15 × < 15 | NS | NS | 2192 | Ex vivo | Resection margin | 1 Pathologist | 55–65 | 68–70 | – | |
| Erickson-Bhatt et al. ( | Handheld OCT, | 9 × 9 | NS | NS | 50 | In vivo and ex vivo | Resection margin | 5 Trained OCT readers | 92 | 92 | – | |
| Nolan et al. ( | OCT, | 11 × 11 | NS | 300–600 | 184 | Ex vivo | Lymph nodes | 3 Analists | 59 | 81 | – | |
| Grieve et al. ( | FF-OCT, | 1 × 1.6 | 0.20–0.30 | 600 | 71 | Ex vivo | Lymph nodes | 1 Pathologist | 92/85 | 83/90 | – | |
| Pancreatico-biliary cancer | Testoni et al. ( | OCT, | 5–10 × 5–10 | 1 | 1 radial mm /s | 100 | Ex vivo | Resection specimens | 3 Observers | 79 | 89 | – |
| Testoni et al. ( | OCT, | 5–10 × 5–10 | 1 | 1 radial mm /s | 11 | In vivo (during ERCP) | Pancreatic duct strictures | NS | 100 | 100 | – | |
| Arvanitakis et al. ( | OCT, | 10 (not exactly described) | 1 | NS | 35 | In vivo (during ERCP) | Biliary duct strictures | 2 Endoscopists | 53 | 100 | – | |
| Iftimia et al. ( | OCT, | 9.5 × 25 | NS | NS | 46 | Ex vivo | Resected cysts | 1 Pathologist | 95 | 95 | – | |
| Van Manen et al. ( | FF-OCT, | 1.5 × 1.0 | > 1 | NS | 100 | Ex vivo | Resected specimens | 2 Pathologists | 72 | 74 | ||
| Oesophageal cancer | Zuccaro et al. ( | OCT, | 12 × 20 | 1 | 3 | 138 | In vivo | AC | 23 Individuals | – | – | 95 |
| Hatta et al. ( | OCT, | 11 × 30 | 1.5 | NS | 144 | In vivo | SCC | 1 Gastroenterologist | – | – | 93 | |
| Hatta et al. ( | OCT, | 11 × 30 | 1.5 | NS | 131 | In vivo | SCC | 1 Gastroenterologist | – | – | 95 | |
| Colorectal cancer | Ashok et al. ( | (Fourier Domain) OCT, | 6.2 × 17 | 1.2 | 5 | 62 | Ex vivo | Resected specimens | Computer | 78 | 74 | – |
| Prostate cancer | Dangle et al. ( | OCT, | 10–20 × 10–20 | 2–3 | 1.5 | 100 | Ex vivo | Resection margin | NS | 70 | 84 | – |
| Lopater et al. ( | FF-OCT, | 1.5 × 1.5 | > 1 | Mean: 261 | 119 | Ex vivo | Biopsies | 3 Pathologists | 63 | 74 | – | |
| Renal cancer | Lee et al. ( | OCT, | 4 × 14 | NS | NS | 35 | Ex vivo | Resected specimens | Three observers | 96 | 96 | – |
| Jain et al. ( | FF-OCT, | 1.5 × 0.8 | NS | NS | 67 | Ex vivo | Resected specimens | 1 Uropathologist | 100 | 100 | – | |
| Wagstaff et al. ( | OCT, | 15 × 20 | NS | NS | 40 | Ex vivo | Renal biopsies | Computer | 86 | 75 | – | |
| Bladder cancer | Manyak et al. ( | OCT, | 10 × 15 | 1 | 1.5 | 87 | Ex vivo | Biopsies | 1 Reviewer | 100 | 89 | – |
| Hermes et al. ( | OCT, | 3 × 10 | NS | 4–16 | 142 | Ex vivo | Resected specimens | 1 Reviewer | 84 | 78 | – | |
| Goh et al. ( | OCT, | 10 × 20 | 1–2 | 1.5 | 94 | In vivo | Biopsies and resected specimens | 1 Surgeon | 100 | 90 | – | |
| Ren et al. ( | OCT, | 10 × 10 | 2.1 | 8 frames/s | 110 | In vivo | Biopsies | Urologists/OCT researchers | 94 | 81 | – | |
| Karl et al. ( | OCT, | 10 × 20 | 1–2 | 1.5 | 102 | In vivo | biopsies | NS | 100 | 65 | – | |
| Gladkova et al. ( | Cross-polarization OCT, | 15 × 25 | NS | 2 | 360 | Ex vivo | Biopsies | 7 reviewers | 94 | 84 | – | |
| Montagne et al. ( | FF-OCT, | 1.5 × 1.0 | > 1 | NS | 24 | Ex vivo | Resected specimens | 2 unexperienced reviewers; 1 FF-OCT expert | Unexperienced: 93 Expert:100 | Unexperienced: 78 Expert: 89 | – | |
| Ovarian cancer | Nandy et al. ( | FF-OCT, | 1.6 × 3.9 | NS | NS | 56 | Ex vivo | Resected specimens | Computer: logistic classifier model | 92 | 88 | – |
OCT optical coherence tomography, NS not specified, HD-OCT high definition optical coherence tomography, SCC squamous cell carcinoma, AC adenocarcinoma, PDC poorly differentiated carcinoma, FF-OCT full-field optical coherence tomography
Fig. 2Example of corresponding OCT and histology images of two melanomas Upper panel (a, c): Hematoxylin and eosin (H&E) images of a superficial spreading melanoma. Lower panel (b, d): OCT images of distorted skin architecture, including large vertically arranged icicle-shaped structures (*). Prominent hyperreflective structures are corresponding to dense collagen cords of encapsulated tumor lobules.
Reprinted by permission from Elsevier: Journal of the American Academy of Dermatology (Gambichler et al. 2007). © 2007
Fig. 3Handheld OCT during breast cancer surgery. Upper panel: normal breast tissue with well-defined boundaries, linear structures, and regular texture. Middle panel: arrow shows an example of a ductal carcinoma in situ, characterized by irregular texture and significant shadowing. Lower panel: an example of an invasive ductal carcinoma (arrows) showing regions with disturbed tissue architecture.
Reprinted by permission from Springer Nature: Annals of Surgical Oncology (Zysk et al. 2015). © 2015
Fig. 4FF-OCT images of the pancreas. Upper panel: FF-OCT image and corresponding hematoxylin and eosin (H&E) image of normal pancreatic tissue. Lower panel: an example of an FF-OCT image of a moderately differentiated pancreatic adenocarcinoma with corresponding H&E image, showing tumor cells infiltrating into fat tissue (Bar = 250 µm)
Fig. 5Example of endoscopic OCT of an esophageal squamous cell carcinoma. Corresponding OCT (a) and histology (b) image of tumor invasion in the submucosal layer, resulting in a loss of the five-layered architecture (Bar = 1000 µm).
Reprinted by permission from Elsevier: Gastrointestinal Endoscopy (Hatta et al. 2010). © 2010